 | Reviva Pharmaceuticals Holdings | |||
| NCM : RVPH || Location: United States | ||||
$3.02-0.04 (-1.31%) |
0.08 M | 2.9 - 3.13 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 1.058 M |
| March 15, 2024 | 0.651 M |
| Feb. 29, 2024 | 0.858 M |
| Feb. 15, 2024 | 1.015 M |
| Jan. 31, 2024 | 0.840 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.36 | -0.35 | 2.67% |
| 09/30/2023 | -0.37 | -0.44 | -17.87% |
| 06/30/2023 | -0.28 | -0.55 | -95.38% |
| 03/31/2023 | -0.33 | -0.30 | 9.50% |
| 12/31/2022 | -0.22 | -0.38 | -69.34% |
RVPH Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 27.919M | Shares Float | 21.129M |
| Short Float | 1.058M | Market Cap | 84.32M |
| Institution ownership | 18.78% | Insider ownership | 17.768% |
| Earnings Date | 05/13/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -1.65 | Forward EPS | -1.49 |